News
Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.
13h
MedPage Today on MSNDetectable ctDNA Before Adjuvant Therapy for Melanoma May Predict RecurrenceDroplet digital PCR measurements of circulating tumor (ct)DNA to assess minimal residual disease before the initiation of adjuvant therapy and during follow-up for patients with resected stage III ...
1d
News-Medical.Net on MSNBlood test for tumor DNA may predict melanoma recurrenceMonitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
The five-year deal to create a joint AI Innovation Lab, which will be reviewed every year, will initially focus on applying AI across Novartis’ internal processes. The aim is to create a data ...
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.Led by researchers ...
The surge in layoffs comes amidst concerns over the impact of President Donald Trump’s tariffs on the nation’s product ...
Entrepreneurial CMO 50 list recognizes fifty chief marketers whose approach to driving growth is charting new paths.
2d
GlobalData on MSNVerve’s shares jump by more than 26% on Lilly-partnered gene therapy dataPhase Ib results show VERVE-102 reduced LDL-C levels with no serious safety issues, unlike Verve’s VERVE-101 programme.
Verve Therapeutics has generated evidence its PCSK9 pivot could pay off. | Verve Therapeutics has generated evidence its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results